Definitive high-dose-rate endobronchial brachytherapy of bronchial stump for lung cancer after surgery

HDR-BT of a stump recurrence or after nonradical resection leads to a long-term OS rate in patients with localized lung cancer and could be considered curative. We found no correlations between OS and chosen clinical data; adjuvant HDR-BT gave better results.